The No Passes for Polluters Act of 2026 requires Congress to explicitly approve any exemptions from Clean Air Act regulations before the President or federal agencies can use them. Under this bill, the President must submit a detailed message to both houses of Congress explaining the reasons and facts behind any proposed exemption, which then triggers a special legislative process. To pass such an exemption, a joint resolution must be approved by a two-thirds vote in both the Senate and the House of Representatives, with limited debate and no amendments allowed. Additionally, the Comptroller General will review these proposals to ensure they have legal authority, and any unauthorized use of exemptions could lead to civil lawsuits. The legislation also mandates that the President reconsider certain executive branch emissions regulations every three years.
The Protecting Immigrants From Legal Exploitation Act of 2026 aims to combat fraud by increasing criminal penalties for individuals who falsely represent themselves as immigration lawyers or provide fraudulent services. It requires non-lawyer immigration service providers to identify themselves on applications and allows victims of unauthorized practice of law to withdraw and resubmit their immigration forms without penalty. The bill also empowers the Attorney General to issue civil injunctions against fraudulent providers and mandates that convicted fraudsters reimburse their clients for services rendered. To support legitimate legal aid, the legislation authorizes funding for outreach programs and grants to nonprofit organizations that provide direct legal assistance to immigrants.
The FAIR Credit Act amends the Fair Credit Reporting Act to improve the accuracy of consumer credit reports and provide relief to specific groups of borrowers. It directly affects consumers, creditors, and credit reporting agencies by changing how adverse information is reported and how certain debts are handled. Key provisions include shortening the time most negative credit items remain on a report from ten to seven years and requiring the removal of fully paid or settled debts after 45 days. The bill also prohibits medical debt from appearing on credit reports, offers credit restoration for victims of predatory mortgage lending and deceptive education programs, and allows victims of economic abuse to have related adverse information removed. Additionally, the legislation expands protections against identity theft by enhancing fraud alert options, mandating free credit monitoring for certain vulnerable groups, and ensuring that inquiries resulting from fraud do not negatively impact credit scores.
HR 6529, the Protecting Families from AI Data Center Energy Costs Act, mandates the Federal Energy Regulatory Commission (FERC) to hold a technical conference within 90 days of enactment. The conference will include AI data centers, utilities, and ratepayer advocates to develop strategies protecting residential and small commercial customers from rising energy costs caused by large energy users. FERC must then submit a report with recommendations to Congress within 180 days. This procedural bill directly affects households and small businesses facing potential rate increases due to AI data center energy demands.
The NIH IMPROVE Act (HR 6238) establishes a new NIH research initiative focused on improving maternal health outcomes in the U.S. It directly affects pregnant and postpartum women, particularly those in communities experiencing health disparities linked to higher maternal mortality and severe maternal morbidity. The bill authorizes $73.4 million annually (2026-2031) for NIH to fund research targeting preventable causes of maternal deaths, reduce health disparities, and evaluate community-based interventions. Key provisions require NIH to advance evidence-based solutions through grants and studies on biological, behavioral, and regional factors affecting maternal health before, during, and after pregnancy.
This bill reauthorizes funding for the C.W. Bill Young Cell Transplantation Program, setting $31 million for fiscal year 2025 and $33 million annually for fiscal years 2027-2031. It also extends the deadline for the national cord blood inventory program from 2026 to 2031. The legislation directly affects stem cell research programs and cord blood banks by maintaining federal funding levels and prolonging the inventory program’s timeline. These provisions ensure continuity for existing research infrastructure and blood bank operations without introducing new policy changes.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
This bill establishes the INCLUDE Project at the National Institutes of Health (NIH) to advance research on Down syndrome and related health conditions. It requires NIH to fund high-risk studies on trisomy 21, support inclusive clinical trials for people with Down syndrome across all ages, and investigate co-occurring conditions like Alzheimer’s disease and autoimmunity. The law mandates NIH coordination across its institutes, consultation with patient advocates, and biennial reports to Congress detailing funded research and its real-world applications. The project directly affects individuals with Down syndrome, their families, and medical researchers, aiming to improve diagnosis, treatment, and quality of life through targeted scientific efforts.
HR 2821, the FDA Modernization Act 3.0, requires the FDA to update regulatory language within one year of enactment. It directs the agency to replace all references to "animal tests" with "nonclinical tests" in 22 specific sections of the Code of Federal Regulations related to drug development and approval processes. The bill also adds a definition for "nonclinical test" into relevant FDA regulations to align with prior legislative changes. This update applies directly to pharmaceutical manufacturers and FDA reviewers who follow these regulatory guidelines during drug development. The changes aim to modernize terminology without altering current testing requirements.
This bill requires Medicare to create separate payment codes for ultralightweight manual wheelchairs based on their frame material (specifically titanium or carbon fiber vs. other materials), starting in 2026. It ensures Medicare pays the standard rate for titanium/carbon fiber wheelchairs regardless of material, while allowing suppliers to charge beneficiaries the difference between Medicare's payment and their actual cost. Beneficiaries must receive a notice about potential additional costs before purchasing or renting such wheelchairs. The bill directly affects Medicare beneficiaries needing these specialized wheelchairs and the suppliers who provide them.
The Judicial Integrity Act amends federal law to clarify which judges and Supreme Court justices must recuse themselves from cases involving personal financial interests. It requires that any exemptions from these conflict-of-interest rules be established through a formal regulation issued by the Judicial Conference of the United States, which must include public notice and a comment period. This change ensures that decisions about whether a financial interest is too small to matter are made transparently rather than through individual waivers. The bill directly affects all federal judges and Supreme Court justices by tightening the standards for when they can participate in cases where they have a financial stake.
The Justice is BLIND Act of 2026 requires federal judges, including justices, magistrate judges, and bankruptcy judges, along with their spouses and dependent children, to place specific financial investments into qualified blind trusts within 90 days of taking office or enactment. This rule applies to securities, commodities, and derivatives but excludes widely held mutual funds, U.S. Treasury bonds, and income earned by spouses or children from their own jobs. The bill also mandates that these judges publicly attest to the establishment of the trust or confirm they hold no covered financial interests, with these reports made available online. Additionally, the law prohibits judges from dissolving or controlling these trusts for 180 days after they leave their judicial positions to prevent immediate conflicts of interest.
